HCA Healthcare is the dominant US for-profit hospital operator, benefiting from sustained admissions growth, favorable payor mix shifts toward commercial, and operating leverage on labor cost normalization. Sun Belt geographic exposure aligns with US demographic migration trends. Capital returns are aggressive. Regulatory risk on 340B and Medicare site-neutral payments remains a watch item.
Thesis reviewed May 29, 2026
HCA Healthcare Inc. is headquartered in United States, which is currently showing elevated risk signals.
🇺🇸United States82EXITView United States risk detail →🏥Healthcare33NEUTRAL| Ticker | Company | Score | Gap | Signal Δ | Action |
|---|---|---|---|---|---|
| CVS | CVS Health Corporation | 40 | +15% | ↓3% | AVOID |
| HCA | HCA Healthcare Inc. | 40 | +9% | ↓3% | EARLY |
| UNH | UnitedHealth Group Inc. | 37 | +16% | ↓3% | AVOID |
| TMO | Thermo Fisher Scientific Inc. | 37 | +11% | ↓3% | EARLY |
| CI | The Cigna Group | 37 | +9% | ↓3% | NEUTRAL |
| ELV | Elevance Health Inc. | 37 | +7% | ↓3% | NEUTRAL |
| TEVA | Teva Pharmaceutical Industries Ltd. | 37 | +9% | ↓3% | NEUTRAL |
Investors who hold HCA may also have indirect exposure through these country funds.
HCA admissions growth +4% in Q1 with improving payor mix
HCA raises 2026 guidance on Sun Belt strength
Estimates · Yahoo Finance · Not audited figures
[House Hearing, 119 Congress] [From the U.S. Government Publishing Office] LOWERING THE COST OF HEALTHCARE: TECHNOLOGY'S ROLE IN DRIVING AFFORDABILITY ======================================================================= JOINT HEARING before the SUBCOMMITTEE ON ECONOMIC GROWTH, ENERGY POLICY, AND REGULATORY AFFAIRS and the …
[House Hearing, 119 Congress] [From the U.S. Government Publishing Office] HARNESSING BIOMEDICAL INNOVATION: MODERNIZING VA HEALTHCARE FOR THE FUTURE ======================================================================= HEARING before the COMMITTEE ON VETERANS' AFFAIRS U.S. HOUSE OF REPRESENTATIVES …
| Politician | Party | Type | Amount | Trade Date | Return |
|---|---|---|---|---|---|
| Jared MoskowitzFL | Buy | $1k–$15k | Jun 17, 26 | ||
| Alan Armstrong | Buy | $1k–$15k | Mar 27, 26 |